Search for: "Novartis Ag"
Results 301 - 320
of 440
Sort by Relevance
|
Sort by Date
23 Sep 2010, 9:36 am
Food and Drug Administration ("FDA") approved Fingolimod capsules (Gilenya, Novartis International AG) for reducing the frequency of relapses and delaying the accumulation of disabling symptoms in relapsing forms of Multiple Sclerosis ("MS"). [read post]
14 Sep 2010, 1:29 am
This exclusion has been expensively interpreted by patent office and the courts: notably, the term ‘efficacy’ in the explanation to Section 3(d) of the Patents Act, 1970 has been interpreted in Novartis AG & Another v. [read post]
6 Sep 2010, 10:01 am
Another failed mistake of age defense based on a MySpace misreported age, this time in the context of a military discharge [read post]
25 Aug 2010, 7:37 am
The average age of the patient was 60 years of age and the trial that exposed the risks lasted an average of 2.7 years. [read post]
19 Aug 2010, 9:02 pm
Depending on the product in question, competition concerns arose in either a few or a larger number of EC member states.The FTC complaint and proposed consent order, In the Matter of Novartis AG, FTC Dkt. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Levitra (Vardenafil) – US: Patent infringement complaint following a Paragraph IV certification: Bayer Schering Pharma AG et al. v. [read post]
27 Jul 2010, 8:20 am
” My “in group” is the group of people who are like me in salient ways such as gender, race, religion, age, educational background, profession, family status, etc. [read post]
22 Jul 2010, 8:35 am
Ian Bryan, IP Counsel, GE Healthcare Vineet Kohli, Senior Patent Attorney, Merck John Beatty, Patent Procedures Management, European Patent Office Dr Roman Maksymiw, Head of Division, German Patent and Trademark Office, DPMA Lawrence Cullen, Deputy Director, IPO Dr Scott Alban, Head of IP, MedImmune Allen Norris, Vice President, Head Group IP, UCB Pharma SA Peter Thomsen, Manager Global IP Litigation and Global Policy, Novartis International AG Morten… [read post]
21 Jul 2010, 4:27 pm
An interviewer cannot ask questions about a person's age, race, national origin, gender, disability, sexual orientation, or religion. [read post]
14 Jul 2010, 6:47 pm
Abbott Laboratories Ltd v Medinol Ltd (PatLit) US: Analysis shows patent use codes have doubled since August 2003 (FDA Law Blog) US: House slips pay-for-delay provision into Appropriations Bill (Patent Docs) US: Novartis challenges USPTO’s interim procedure for requesting PTA recalculations (Patent Docs) US: Seven actions related to Enzo’s patents for detecting DNA stayed pending Supreme Court review (Patent Docs) US: Review and correction of the patent term adjustment… [read post]
12 Jul 2010, 9:59 pm
By Donald Zuhn -- Last week, Novartis AG and Novartis Vaccines and Diagnostics, Inc. filed a complaint against U.S. [read post]
10 Jul 2010, 1:53 pm
According to a recent wage and hour ruling that our Riverside, California employment attorneys have been following, sales representatives of Novartis AG, are supported by federal, New York state, and California state wage and hour laws that require overtime compensation. [read post]
6 Jul 2010, 9:59 pm
Click here for further details.The decision of the Court of Appeal for England and Wales in Actavis UK Limited v Novartis AG -- which has the distinction of being the most-commented-upon ruling ever to have been posted on this weblog -- was bound to be the subject of an appeal. [read post]
6 Jul 2010, 12:15 pm
In coverage of today's ruling, Bloomberg News reports that "Novartis AG's Salespeople Covered by Wage Laws, U.S. [read post]
21 Jun 2010, 8:45 am
About the Authors Philip Grubb is an Intellectual Property Consultant; formerly Intellectual Property Counsel, Novartis International AG; Adjunct professor, Franklin Pierce Law Center, Concord, NH. [read post]
15 Jun 2010, 7:50 pm
– slow progress of NZ patent reform (PatLit) Netherlands District Court The Hague – Ex parte decision against Drogisterij.net in extended wear contact lens patent dispute: Novartis v. [read post]
15 Jun 2010, 3:00 am
With dementia on the rise and as our society continues to age, many pharmaceutical companies are taking aim at inventing a drug that will reduce if not cure dementia all together. [read post]
9 Jun 2010, 8:28 am
This liability also extends to you if your supervisor or manager commits harassment based on race, color, sex, religion, national activity, age, protected activity, and disability. [read post]
26 May 2010, 3:01 pm
Novartis AG, where the English judge analyzes the problem-solution approach as practised by the EPO and concludes in paragraph 63 that the decision on the obviousness of the solution provided by the patent under consideration to which he had come would have been the same if the problem-solution approach had been applied). [2.5] In its decision T 665/95 (cited by the impugned decision) the Board has not considered this principle to be an obstacle when it refused further taking of… [read post]
23 May 2010, 10:46 am
In this age of government regulation and strict enforcement policies, the jury verdict is a wake-up call to companies who ignore, condone, or encourage sex discrimination at the workplace. [read post]
